October 23rd, 2012

Introducing the Healthy Project

From Dr. Jack Groppel, Ph.D., co-founder of the Human Performance Institute, and Vice President of Applied Science and Performance Training at Wellness & Prevention, Inc., a Johnson & Johnson company.


Today I joined a number of my colleagues at Johnson & Johnson and some of our partner organizations in New York City to introduce The Healthy Project.  What’s The Healthy Project?  It’s a movement to demonstrate how anyone, anywhere can make a change for themselves, their neighbors, their family or their community to become and stay healthy.

The world has become increasingly unhealthy.  Sedentary lifestyles, poor nutrition and stress are all contributing factors to this change, and it’s compounded by anxiety and limited access to basic health information, so that the solutions frequently overwhelm rather than inspire.  The result is that people have stopped listening and taking action to improve their health.  The Healthy Project is a way to help change that.

One of those changes will be accomplished by activating healthy communities – through programs like the Johnson & Johnson Gateway to a Healthy Community ™ – Healthier Kids program, a community partnership to get children moving to help combat the epidemic of childhood obesity in our cities.  The second way is by activating healthy personal empowerment through digital platforms that provide health information and remind people about doctor visits, taking medication and more.  And the third way is to activate behavior change and healthy approaches to wellness and human performance through personalized digital health coaching, energy management training,  and other innovative programs.

Read More

October 18th, 2012

We Got Mail! … About Sustainable Palm Oil?

Leaves of Gratitude

By Paulette Frank, Vice President of Sustainability and EH&S, Johnson & Johnson Family of Consumer Companies

Remember when you were little, and how excited you felt when a piece of mail arrived and it was actually for you? And the bigger the envelope, the more exciting it was? Every once in awhile, a piece of mail arrives that brings back that feeling of wonder and excitement. I received a piece of mail like that a few weeks ago, at my office.

It was a big, yellow envelope from the Philadelphia Zoo. The Philadelphia Zoo sent us mail?! Inside the package, there was a cardboard tree and a smaller envelope filled with colorful paper leaves. Each leaf had a message from a child who had visited the zoo and decided to say “thank you” to Johnson & Johnson for caring about orangutans. Caring about orangutans?! What could the Philadelphia Zoo, Johnson & Johnson and orangutans possibly have in common? Turns out, that would be something called palm oil.

At Johnson & Johnson, we use ingredients like soap chips, surfactants, emollients and emulsifiers, that are derived from palm oil in many of our personal care products. And much of the world’s palm oil comes from Indonesia and Malaysia where orangutans live.

Read More

October 17th, 2012

Johnson & Johnson Successfully Combating Childhood Obesity One Student At A Time

 From Alexis LaScala, Johnson & Johnson Corporate External Relations Team

Recently, I attended a unique event to celebrate and recognize educators from four U.S. cities for their successful implementation of the Johnson & Johnson Gateway to a Healthy Community ™ – Healthier Kids (GHC-HK) program, an innovative effort to help combat childhood obesity. GHC-HK is a core curriculum-based program that emphasizes increasing physical activity in schools in Atlanta, Houston, Newark and Philadelphia. A key component is a proven program called Activity Works (AW) that delivers 12-minute video/audio exercise bursts in classrooms that helps to maximize academic performance and meet state mandates for physical education. Through this program, in just 85 days during the 2011-2012 school year, nearly 28,000 elementary school students in grades K-3 in over 1,100 classrooms in four cities burned more than 61 million calories!

While Johnson & Johnson and the GHC-HK program deserve kudos for leadership and innovation in helping to combat childhood obesity, the stars of the event were the students and the school districts and stakeholders who brought the program to the schools in those four cities.

A highlight of the event I attended at Newark’s Park Elementary School was a live demonstration of more than 100 students who jumped, pushed, pulled, reached and galloped through an AW adventure called Wonders of the World.  Like all Activity Works adventures, Wonders brings learning and exercise together and it was clear that the children were enthusiastically enjoying every moment of it.

Read More

October 16th, 2012

CleanMed Europe 2012: Sustainability’s Promise for Business Opportunity and Healthcare Change

Momchil Jelev
Policy Assistant, WW Environment, Health & Safety, WW Government Affairs & Policy


When we speak about healthcare in Europe, the word ‘sustainability’ is used often. From the outset of the economic crisis in 2008, policymakers, ministries of health, customers and payers all have focused on sustainable financial systems and sustainable healthcare systems – often as separate paths to achieve results. As budgets are shrinking, innovative ways to maintain current social and healthcare systems for the long term must be employed. As I attended CleanMed Europe recently, I was pleased to see that a broader alternative discussion is emerging- one that marries financial and systemic sustainability in healthcare.

Pictured from left to right: Momchil Jelev, Phil Dahlin, Keith Sutter, Gary Cohen, Erol Odabasi, Al Iannuzzi

This year, CleanMed returned to Europe for the first time since 2005. As a sponsor, Johnson & Johnson and SterilMed were pleased to attend the conference hosted in Malmo, Sweden and talk with our customers and colleagues about the ways in which we are helping to make hospitals and healthcare more sustainable. We also shared a recently-published whitepaper based on recent findings, which revealed that our customers across the globe have begun and will continue to demand more sustainable healthcare products.

Read More

October 10th, 2012

Breaking the Chains of Stigma Around Mental Illness

By Husseini K. Manji, MD, Global Head, Neuroscience Therapeutic Area, Janssen Research & Development, LLC

Today is World Mental Health Day, a day that according to the World Health Organization “raises public awareness about mental health issues…promotes open discussion of mental disorders, and investments in prevention, promotion and treatment services.” To me, it also is a reminder of the work that still must be done. At Janssen, we believe in the power of recovery from mental illness, and we know that recovery is possible only with appropriate treatment. To spark the process of recovery there has to be public recognition that brain disorders are treatable and there must be no shame and no stigma attached.

That is why Janssen Research & Development partnered with Museum Dr. Guislain, a Belgian mental health museum earlier this year, to sponsor and present the inaugural Dr. Guislain “Breaking the Chains of Stigma” Award. The Award honors the legacy of Dr. Joseph Guislain (1797-1860), the first Belgian psychiatrist to provide scientifically-based treatment for patients with mental illness, and a staunch patient advocate. The award is an important component of the Janssen and Johnson & Johnson Healthy Minds initiative, which aims to encourage collaboration among biotechnology, pharmaceutical, and public-sector partners to accelerate the discovery of new therapeutic solutions for diseases and disorders of the brain, as well as support the mental health community and various advocacy organizations and projects.

Read More

October 2nd, 2012

In Memory of James E. Burke

We are saddened this week by the news that former Johnson & Johnson Chairman and CEO James E. Burke passed away on Friday, September 28. Mr. Burke was an extraordinary leader and a testament to all that we stand for as a company.
Please join us in remembering and honoring Mr. Burke and the contributions he made to Johnson & Johnson and to the world. Johnson & Johnson paid tribute today with this advertisement in several major U.S. newspapers:

To learn more about Mr. Burke and his career, please read our news release and our post on the Kilmer House blog.

Read More

October 2nd, 2012

A Young Science Journalist’s Impressions on the 2012 Dr. Paul Janssen Award

By Bob Hackett, Science Journalism Intern at Janssen R&D

I read in the theme of this year’s Dr. Paul Janssen AwardThe Power of Science to Change the World—an unwritten corollary; how apparently small things can disproportionately impact the large.  Science brims with underdogs.  And science progresses through the dust clouds they leave in their wake.

Left to right: Dr. Gary Ruvkun and Dr. Victor Ambros

2012 winners holding their respective Dr. Paul Janssen Awards

So it was with this year’s winners.  Dr. Victor Ambros and Dr. Gary Ruvkun co-discovered micro-RNAs, a class of miniature molecules, essential to life (human included), by looking inside unwitting, minuscule roundworms known as Caenorhabditis elegans (C. elegans for short), a nematode.  Micro-RNAs are, as their name suggests, tiny.  Typically only twenty-one nucleotides long.  (Coincidentally, as many letters as are in “Caenorhabditis elegans”.)  Yet scientists believe micro-RNAs to be central regulators of gene expression and development—essential to our every breath, movement, sight, sleep, digestion, cognition.  Without them life is jeopardized and abnormalities abound.  So small yet so vital.

My love for science stems from such underdogs.  The micro-molecules, the mini-worms, the first few researchers who devote themselves to poking around inside…

If you wonder why a company like Janssen would be interested in such arcane science, it is because Dr.

Read More

September 21st, 2012

On World Alzheimer’s Day, Let’s Work to Eliminate Stigma about Dementia

By Husseini K. Manji, MD, Global Head, Neuroscience Therapeutic Area, Janssen Research & Development, LLC

September is World Alzheimer’s Month, and today is World Alzheimer’s Day – the culmination of a coordinated international effort to raise awareness and challenge the stigma around dementia.

The 2012 World Alzheimer Report released today focuses on the global impact of stigma associated with dementia, including a review of current knowledge in the area and results of a global survey on stigma.  Not surprisingly, the stigma and associated social exclusion experienced by people with Alzheimer’s and their caregivers is one of the disease’s most devastating effects.  According to the report, 40 percent of people with dementia say they have been avoided or treated differently because of their diagnosis and are not included in everyday life.   Statistics like this are all the more meaningful because most of us have been personally affected by Alzheimer’s in our own families, or know someone who has.

More than 36 million people worldwide are living with dementia and by 2030, this number will have nearly doubled to 66 million. These numbers are staggering and the need is greater than ever for new solutions for patients and their loved ones.  But there is also reason to hope.  Today, we have a greater understanding of Alzheimer’s disease, and are learning more about ways to predict and potentially slow its progress.  Advances will come through increased collaboration between scientists from industry, government and academia.

Read More

September 12th, 2012

Finding Support When Facing Serious Illness

By Denise Sitarik, RN, Vice President, Johnson & Johnson Patient Assistance Foundation, Inc.

In her book Illness as Metaphor Susan Sontag wrote that “everyone who is born holds dual citizenship, in the kingdom of the well and in the kingdom of the sick…[and] sooner or later each of us is obliged, at least for a spell, to identify ourselves as citizens of that other place.”

It’s true that we all want to remain permanent citizens in the world of good health, but at some point we all face illness, whether our own or that of a loved one. As a registered nurse, I know first-hand the challenges patients experience when they are diagnosed with a chronic illness:  physical pain and discomfort, fatigue, fear, and anxiety.  I have seen the physical and emotional toll chronic illness takes on patients, caregivers and their families and the tremendous energy required to deal with the day-to-day difficulties of illness. There is also the challenge of navigating the complexity of the US healthcare system. The sudden dependence on family and friends and the worry that comes from the financial impact of illness can be overwhelming.

At the Johnson & Johnson Patient Assistance Foundation (JJPAF), we try to help with the burden of chronic illness by assisting patients who meet eligibility requirements to get medicines they need.

Read More

September 7th, 2012

Janssen Featured at White House World Hepatitis Day Activities


By Gaston Picchio, Hepatitis Disease Area Leader, Janssen

As a scientist involved in hepatitis C research for 20 years, it is very gratifying to see the recent explosion of advances against this disease. Often called the silent epidemic, hepatitis C is the most prevalent form of viral hepatitis in the United States.  Globally, it is estimated that three percent of the world’s population–up to 170 million people–is currently infected with hepatitis C.  In the United States, an estimated 3.2 million people are infected, but most don’t know it, and every year approximately 12,000 Americans die from hepatitis C-related liver disease.

While most days at Janssen we strive to make a difference for patients through our research to create simpler, safer and more effective treatments for hepatitis C, on August 2, at the second annual White House World Hepatitis Day Event, I had the opportunity to share my thoughts about how Janssen can help make a difference in another way: through public and industry partnerships.

Janssen is one of several companies that were invited to the White House to be part of the discussion about the current state of viral hepatitis in the United States. The event was sponsored by The Office of National AIDS Policy in collaboration with the U.S.

Read More